Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | 1,700 | reported | 21 May 2026 | tx 2+5,100 |
| Apellis Pharmaceuticals, Inc. | 0 | reported | 14 May 2026 | tx 10+47,123−63,416 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | SPRUCE BIOSCIENCES, INC. | 1,700 | 0.00 USD | deriv |
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 17,051 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8,332 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 664 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7,297 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 14,684 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 15,388 | — | deriv |
| 01 Jan 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 7,961 | 0.00 USD | |
| 01 Jan 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 14,684 | 0.00 USD | deriv |
| 11 Dec 2025 | GRANT_AWARD | SPRUCE BIOSCIENCES, INC. | 3,400 | 0.00 USD | deriv |
| 08 Jan 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 9,090 | 0.00 USD | |
| 08 Jan 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 15,388 | 33.00 USD | deriv |